Skip to main content
SpringerLink
Log in
Palgrave Macmillan
Book cover

Ways of Regulating Drugs in the 19th and 20th Centuries

  • Book
  • © 2013

Overview

Editors:
  1. Jean-Paul Gaudillière

    1. CERMES3, CNRS, Paris, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Volker Hess

    1. Institute for the History of Medicine, Charité University Medicine Berlin, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Science, Technology and Medicine in Modern History (STMMH)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-xiv
    Download chapter PDF

  2. General Introduction

    • Jean-Paul Gaudillière, Volker Hess
    Pages 1-16

  3. Secrets, Bureaucracy, and the Public: Drug Regulation in Early 19th-Century Prussia

    • Volker Hess
    Pages 17-42

  4. Making Salvarsan: Experimental Therapy and the Development and Marketing of Salvarsan at the Crossroads of Science, Clinical Medicine, Industry, and Public Health

    • Axel C. Hüntelmann
    Pages 43-65

  5. Professional and Industrial Drug Regulation in France and Germany: The Trajectories of Plant Extracts

    • Jean-Paul Gaudillière
    Pages 66-96

  6. Making Risks Visible: The Science, Politics, and Regulation of Adverse Drug Reactions

    • Harry M. Marks
    Pages 97-120

  7. Regulating Drugs, Regulating Diseases: Consumerism and the US Tolbutamide Controversy

    • Jeremy A. Greene
    Pages 121-150

  8. Thalidomide, Drug Safety Regulation, and the British Pharmaceutical Industry: The Case of Imperial Chemical Industries

    • Viviane Quirke
    Pages 151-180

  9. What’s in a Pill? On the Informational Enrichment of Anti-Cancer Drugs

    • Alberto Cambrosio, Peter Keating, Andrei Mogoutov
    Pages 181-205

  10. Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer

    • Ilana Löwy
    Pages 206-227

  11. AZT and Drug Regulatory Reform in the Late 20th-Century US

    • Donna A. Messner
    Pages 228-244

  12. Professional, Industrial, and Juridical Regulation of Drugs: The 1953 Stalinon Case and Pharmaceutical Reform in Postwar France

    • Christian Bonah
    Pages 245-269

  13. Managing Double Binds in the Pharmaceutical Prescription Market: The Case of Halcion

    • Toine Pieters, Stephen Snelders
    Pages 270-286

  14. Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens, and Generics Laboratories in Brazil and India

    • Maurice Cassier
    Pages 287-317

  15. Back Matter

    Pages 319-327
    Download chapter PDF
Back to top

Keywords

About this book

This collection takes the perspective that the historiography of science, technology, and medicine needs a broader approach toward regulation. The authors explore the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and means of intervention chosen to tame drugs in factories, consulting rooms and courts.

Reviews

"Ways of Regulating Drugs presents twelve very wide-ranging, generally excellent, and often quite specialized chapters. ... This is all thought-provoking, quality work. The 'ways of regulating' framework brings wonderfully sophisticated analysis to the history of drug regulation, especially when focused on state, industrial, professional, and juridical actors whose power to create and enforce is evident." - David Herzberg, University at Buffalo, USA

"Ways of Regulating Drugs offers a stimulating history of the pharmaceutical products and industry during the 19th and 20th century. The choice of the authors is to assume different ways of analysing drug trajectories the demonstration is really convincing: it shows that if drugs aren't like other goods and if public health refers to a specific market, their history might not remain at the frontiers of the history of sciences, economic history or political history. The question of drug trajectories and of their regulations has become crucial enough to be liable to resolutely and fruitful multidisciplinary approaches, of which this book is a major issue." - Sophie Chauveau, Gesnerus, 71, (2014)

Editors and Affiliations

  • CERMES3, CNRS, Paris, France

    Jean-Paul Gaudillière

  • Institute for the History of Medicine, Charité University Medicine Berlin, Germany

    Volker Hess

About the editors

CHRISTIAN BONAH Professor for the History of Medical and Health Sciences at the University of Strasbourg, France ALBERTO CAMBROSIO Professor in the Department of Social Studies of Medicine at McGill University, Canada MAURICE CASSIER Sociologist and a Senior Researcher for the National Centre for Scientific Research (CNRS), France JEREMY GREENE Assistant Professor of the History of Science at Harvard University, USA AXEL C. HÜNTELMANN Academic Assistant at the Institute for the History Theory and Ethics of Medicine at the Gutenberg University in Mainz, Germany PETER KEATING Professor of History at the Université du Québec à Montréal, Canada ILANA LÖWY Senior Researcher at INSERM (Institut National de la Santé et de la Recherche Scientifique), Paris, France HARRY M. MARKS was Associate Professor at the Institute of the History of Medicine, Johns Hopkins University, USA DONNA A. MESSNER Research Director at the Center for Medical Technology Policy in Baltimore, USA TOINE PIETERS Professor of the History of Pharmacy at Utrecht University, the Netherlands VIVIANE QUIRKE RCUK Academic Fellow and Senior Lecturer in Modern History and History at Oxford Brookes University, UK STEPHEN SNELDERS Research Fellow at the Descartes Centre for the History and Philosophy of the Sciences and the Humanities at Utrecht University, the Netherlands

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation